IDEXX LABORATORIES INC /DE (IDXX) Total liabilities 2016–2025
IDEXX LABORATORIES INC /DE (IDXX) total liabilities at each fiscal year-end, per SEC filings.
$1.7BFY2025 · since FY2016: $1.6B → $1.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.7B | +2.8% |
| FY2024 | $1.7B | -4.4% |
| FY2023 | $1.8B | -17.0% |
| FY2022 | $2.1B | +22.4% |
| FY2021 | $1.7B | +5.1% |
| FY2020 | $1.7B | +0.4% |
| FY2019 | $1.7B | +7.0% |
| FY2018 | $1.5B | -12.5% |
| FY2017 | $1.8B | +7.8% |
| FY2016 | $1.6B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXX financial trends
IDXX RevenueIDXX Net incomeIDXX Net marginIDXX Gross profitIDXX Gross marginIDXX Operating incomeIDXX Operating marginIDXX Operating cash flowIDXX Free cash flowIDXX Capital expendituresIDXX Return on equityIDXX Stock buybacksIDXX Dividends paidIDXX Total assetsIDXX Shareholders’ equityIDXX overview →